GB0613584D0 - Therapeutic compounds - Google Patents
Therapeutic compoundsInfo
- Publication number
- GB0613584D0 GB0613584D0 GBGB0613584.2A GB0613584A GB0613584D0 GB 0613584 D0 GB0613584 D0 GB 0613584D0 GB 0613584 A GB0613584 A GB 0613584A GB 0613584 D0 GB0613584 D0 GB 0613584D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0613584A GB2439923B (en) | 2006-07-07 | 2006-07-07 | Therapeutic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0613584A GB2439923B (en) | 2006-07-07 | 2006-07-07 | Therapeutic compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0613584D0 true GB0613584D0 (en) | 2006-08-16 |
GB2439923A GB2439923A (en) | 2008-01-16 |
GB2439923B GB2439923B (en) | 2011-04-06 |
Family
ID=36926680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0613584A Expired - Fee Related GB2439923B (en) | 2006-07-07 | 2006-07-07 | Therapeutic compounds |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2439923B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106905248B (en) * | 2017-01-20 | 2021-07-16 | 贵州医科大学 | Ligustrazine fused ring compound, pharmaceutical composition thereof and application thereof in medicines |
-
2006
- 2006-07-07 GB GB0613584A patent/GB2439923B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2439923B (en) | 2011-04-06 |
GB2439923A (en) | 2008-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0610680D0 (en) | Therapeutic compounds | |
IL193678A0 (en) | Therapeutic compounds | |
GB0603041D0 (en) | Therapeutic compounds | |
HK1203925A1 (en) | Therapeutic compounds | |
EP2211620A4 (en) | Therapeutic compounds | |
GB0606663D0 (en) | Therapeutic compounds | |
GB0813087D0 (en) | Therapeutic compounds | |
GB0716532D0 (en) | Therapeutic compounds | |
EP2164324A4 (en) | Therapeutic compounds | |
GB0615809D0 (en) | Therapeutic compounds | |
GB0612971D0 (en) | Therapeutic compounds | |
EP2185568A4 (en) | Therapeutic compounds | |
GB0625349D0 (en) | Therapeutic compounds | |
EP2079704A4 (en) | Therapeutic compounds | |
GB0625345D0 (en) | Therapeutic compounds | |
GB0605573D0 (en) | Therapeutic Compounds | |
GB0603455D0 (en) | Therapeutic compounds | |
GB0608269D0 (en) | Therapeutic compounds | |
GB0702862D0 (en) | Therapeutic compounds | |
GB2439923B (en) | Therapeutic compounds | |
GB0708188D0 (en) | Therapeutic compounds | |
GB0610670D0 (en) | Therapeutic compounds | |
GB0604049D0 (en) | Therapeutic compounds | |
GB0611498D0 (en) | Therapeutic compounds | |
GB0614082D0 (en) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application |
Owner name: MAHAUT-SMITH, MARTYN P Free format text: FORMER APPLICANT(S): CAMBRIDGE ENTERPRISE LIMITED Owner name: FUNG, KAM P Free format text: FORMER APPLICANT(S): CAMBRIDGE ENTERPRISE LIMITED Owner name: FUNG, CHING Y E Free format text: FORMER APPLICANT(S): CAMBRIDGE ENTERPRISE LIMITED |
|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20130707 |